Cell Death News and Research

RSS
Smelling for first time results from knowing abnormalities in congenital loss of smell

Smelling for first time results from knowing abnormalities in congenital loss of smell

New mechanism identified for resistance to targeted lung cancer drugs

New mechanism identified for resistance to targeted lung cancer drugs

Johns Hopkins team stops form of blood cancer in its tracks

Johns Hopkins team stops form of blood cancer in its tracks

Surprising new theory on antibiotic resistance

Surprising new theory on antibiotic resistance

Mode of action of EpiCept-licensed cancer compound profiled at AACR

Mode of action of EpiCept-licensed cancer compound profiled at AACR

Miscue of  body's genetic repair system may cause Huntington's disease

Miscue of body's genetic repair system may cause Huntington's disease

Pharmacyclics announces NDA for Xcytrin injection

Pharmacyclics announces NDA for Xcytrin injection

Naturally occurring compound found in many fruits and vegetables as well as red wine, selectively kills leukemia cells

Naturally occurring compound found in many fruits and vegetables as well as red wine, selectively kills leukemia cells

Novel targeted therapy effectively treats acute leukemia

Novel targeted therapy effectively treats acute leukemia

New research may help identify patients most likely to benefit from cisplatin treatment

New research may help identify patients most likely to benefit from cisplatin treatment

Green tea may help protect against Sjogren's syndrome

Green tea may help protect against Sjogren's syndrome

New approach to cystic fibrosis treatment

New approach to cystic fibrosis treatment

OncoGenex Technologies announces data from a Phase II clinical trial of OGX-011

OncoGenex Technologies announces data from a Phase II clinical trial of OGX-011

Nanoparticle delivery system delivers cancer-suppressing gene in M. D. Anderson trial

Nanoparticle delivery system delivers cancer-suppressing gene in M. D. Anderson trial

Avalon Pharmaceuticals announces results of  AVN944 biomarker study

Avalon Pharmaceuticals announces results of AVN944 biomarker study

Clioquinol shows promise in fighting cancer

Clioquinol shows promise in fighting cancer

New hope for spinal cord injury sufferers

New hope for spinal cord injury sufferers

Researchers induce cell death in leukemia

Researchers induce cell death in leukemia

Biomira selects PX-866 as clinical development candidate

Biomira selects PX-866 as clinical development candidate

Snake venom toxin as a treatment for prostate cancer

Snake venom toxin as a treatment for prostate cancer